Showing results (1801-1810 of 5,261) with videos related to
Sort By:
Pageof 527
Oncology|November 20, 2009
The roles of national cancer research institutions in evolving a comprehensive cancer control program in a developing country: experience from UgandaJackson Orem, Henry WabingaOncology|November 20, 2009
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapyMichael I Koukourakis, Alexandra Giatromanolaki, Stuart Winter, et al.Oncology|November 20, 2009
A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancerYousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, et al.Oncology|May 3, 2017
Prognostic Parameters for Patients with Cervical Cancer FIGO Stages IA2-IIB: A Long-Term Follow-UpBogdan Obrzut, Andrzej Semczuk, Maciej Naróg, et al.Oncology|May 5, 2017
Evaluation of the Effectiveness of a Multimodal Complementary Medicine Program for Improving the Quality of Life of Cancer Patients during Adjuvant Radiotherapy and/or Chemotherapy or Outpatient AftercareMartin Domnick, Manju Domnick, Karl-Rüdiger Wiebelitz, et al.Oncology|August 23, 2016
Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?Barbara Kiesewetter, Julius Lukas, Werner Dolak, et al.Oncology|December 2, 2005
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trialJ Souglakos, A Pallis, S Kakolyris, et al.Oncology|December 2, 2005
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanesM Donadio, M Ardine, A Berruti, et al.Oncology|January 1, 1991
Detection of pleiotropic drug resistance by the rapid immunofluorescence assay of drug effects on the cell skeletonH Mujagić, Z MujagićPageof 527